A combination of historical and genetic research shows that flight attendant Gaetan Dugas, a French-Canadian gay man, who became the human epicentre of the US AIDS crisis of the 1980s was simply one of many thousands infected in the years before HIV was recognised.
Research by a historian from the University of Cambridge in the UK and the genetic testing of decades-old blood samples by a team of US scientists has demonstrated that Dugas was not the epidemic's 'Patient Zero'.
Before death, Dugas provided investigators a significant amount of personal information to assist with studies into whether AIDS was caused by sexually transmitted agent.
McKay's research suggests that this, combined with confusion between a letter and a number, contributed to the invention of Patient Zero and the global defamation of Dugas.
McKay's work has added important contextual information to the latest study, led by Michael Worobey from the University of Arizona in the US, and which has compared a new analysis of Dugas's blood with eight other archived serum samples dating back to the late 1970s.
While his research traces this impulse to blame back several centuries, McKay located the immediate roots of the term "Patient Zero" in an early 'cluster study' of US AIDS patients.
Reports emerged in early 1982 of historical sexual links between several gay men with AIDS in Los Angeles and investigators from the US Centers for Disease Control (CDC) undertook a study to interview these men for the names of their sexual contacts.
After 30 years, analysis of the HIV-1 genome taken from Dugas's 1983 blood sample, contextualised through McKay's historical research, shows that he was not even a base case for HIV strains at the time, and that a trail of error and hype led to his condemnation as the so-called Patient Zero.
"In the 1970s, as now, the epidemic was driven by individuals going about their lives unaware they were contracting, and sometimes transmitting, a deadly infection," said McKay.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
